Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.
J Am Chem Soc. 2011 Aug 17;133(32):12338-41. doi: 10.1021/ja203397s. Epub 2011 Jul 26.
Flavin-dependent monooxygenases (FMOs) are involved in important biosynthetic pathways in diverse organisms, including production of the siderophores used for the import and storage of essential iron in serious pathogens. We have shown that the FMO from Aspergillus fumigatus, an ornithine monooxygenase (Af-OMO), is mechanistically similar to its well-studied distant homologues from mammalian liver. The latter are highly promiscuous in their choice of substrates, while Af-OMO is unusually specific. This presents a puzzle: how do Af-OMO and other FMOs of the biosynthetic classes achieve such specificity? We have discovered substantial enhancement in the rate of O(2) activation in Af-OMO in the presence of L-arginine, which acts as a small molecule regulator. Such protein-level regulation could help explain how this and related biosynthetic FMOs manage to couple O(2) activation and substrate hydroxylation to each other and to the appropriate cellular conditions. Given the essentiality of Fe to Af and the avirulence of the Af-OMO gene knock out, inhibitors of Af-OMO are likely to be drug targets against this medically intractable pathogen.
黄素依赖单加氧酶(FMOs)参与多种生物体内重要的生物合成途径,包括产生用于摄取和储存重要铁的铁载体。我们已经表明,来自烟曲霉的 FMO,即鸟氨酸单加氧酶(Af-OMO),在机制上与其在哺乳动物肝脏中研究得很好的远亲同源物相似。后者在选择底物方面非常混杂,而 Af-OMO 则异常特异。这提出了一个难题:Af-OMO 和其他生物合成类别的 FMO 如何实现这种特异性?我们发现,在存在 L-精氨酸的情况下,Af-OMO 中 O2 活化的速率大大提高,L-精氨酸充当小分子调节剂。这种蛋白质水平的调节可以帮助解释这种和相关的生物合成 FMO 如何将 O2 活化和底物羟化彼此偶联,并与适当的细胞条件偶联。鉴于 Fe 对 Af 的必要性以及 Af-OMO 基因敲除的无毒性,Af-OMO 的抑制剂可能是针对这种医学上难以治疗的病原体的药物靶点。